VTNE Pain Management Practice Questions 2026 — D9 (7% of Exam)
---
title: "VTNE Pain Management Practice Questions 2026 — D9 (7% of Exam)"
---
Free VTNE Practice Exam | VTNE Study Guide | VTNE Prep Guide | Free VTNE Flashcards
Introduction
VTNE pain management questions come from Domain 9 (D9), which represents 7% of the total exam — approximately 10–11 scored questions. Although smaller than some other domains, D9 has grown in importance as the veterinary profession has deepened its commitment to evidence-based analgesia. Students who skip pain management content routinely leave multiple points on the table. Pain assessment scales and opioid receptor classification are consistently tested across examination cycles. Knowing which opioid is a full agonist versus a partial agonist versus an antagonist — and what those distinctions mean clinically — is essential preparation for exam day.
What the VTNE Tests in D9 Pain Management
D9 encompasses pain recognition, assessment tools, pharmacological management, and non-pharmacological adjuncts across multiple species. Key content areas include:
Pain assessment scales: Glasgow Composite Measure Pain Scale (GCMPS/CMPS-SF) — gold standard validated scale for dogs; Colorado State University Pain Scale (CSU) — species-specific versions for dogs, cats, horses; IVECCS Acute Pain Scale — commonly used in emergency settings for cats; Numerical Rating Scale (NRS) — 0–10 or 0–4 scale; quick clinical tool; Visual Analog Scale (VAS) — continuous line scale from 'no pain' to 'worst possible pain'; Feline Grimace Scale — validated feline tool; orbital tightening is the primary indicator.
Signs of pain by species: Dogs: guarding, vocalization, facial grimace, altered gait, decreased appetite; Cats: orbital tightening/squinting (Feline Grimace Scale), ear flattening, whisker position change, muzzle tension, hunched posture — cats rarely vocalise pain; Horses: pawing, looking at the flank, flared nostrils, weight shifting, reluctance to bear weight, sweating without exercise.
Opioid classification and receptors: Full mu agonists: morphine, hydromorphone, fentanyl (strongest analgesia; best for moderate-severe pain); Partial mu agonist: buprenorphine (ceiling effect; excellent for cats via oral transmucosal route); Mixed agonist-antagonist: butorphanol (kappa agonist/mu antagonist; mild pain; short 45–90 min duration); Opioid antagonist: naloxone 0.01–0.04 mg/kg IV (reverses ALL opioid effects including analgesia).
NSAIDs: mechanism and safety rules: Mechanism: inhibit COX-1 (protective prostaglandins — GI mucosa, renal perfusion) and COX-2 (inflammatory prostaglandins). Preferential COX-2 inhibitors (meloxicam, carprofen) have better GI safety profiles. Rules: NEVER combine two NSAIDs; NEVER give an NSAID with a corticosteroid; avoid in dehydrated, hypotensive, or renal-compromised patients; withhold 24+ hours before elective surgery to preserve renal autoregulation under anaesthesia.
Local anesthetics: maximum doses: Lidocaine: dog max 4 mg/kg; cat max 2 mg/kg (half of dog). Bupivacaine: dog max 2 mg/kg; cat max 1 mg/kg. Mechanism: sodium channel blockade preventing nerve depolarisation. Toxicity signs: CNS excitation (tremors, seizures), then cardiovascular depression (arrhythmias). Bupivacaine is especially cardiotoxic — never give IV.
Multimodal analgesia: Combining drugs from different analgesic classes to target multiple pain pathways simultaneously. This achieves superior analgesia at lower individual doses, reducing side effects. Classic example: opioid + NSAID + local anaesthetic nerve block.
CRI protocols: Fentanyl CRI: 2–10 mcg/kg/hr dog (titrate to effect); MLK protocol: morphine + lidocaine + ketamine infusion (perioperative pain management); Dexmedetomidine CRI: adjunct analgesic, reduces opioid requirement.
Chronic pain management: Gabapentin 5–10 mg/kg BID-TID (neuropathic pain, central sensitisation, pre-operative anxiolysis in cats); Amantadine (NMDA receptor antagonist — breaks central sensitisation); Tramadol (weak mu agonist — efficacy debated in dogs, better in cats).
Non-pharmacological analgesia: Cold therapy (cryotherapy) — acute inflammation within first 48–72 hours; Heat therapy — chronic pain, muscle tension after acute phase resolves; Acupuncture, laser therapy (PBMT), rehabilitation/physiotherapy.
High-Yield Pain Management Topics
These eight topics consistently appear in VTNE candidate reports and practice exam analytics as the most frequently tested content in D9:
1. Opioid classification — Full agonist (morphine, hydromorphone, fentanyl) versus partial agonist with ceiling effect (buprenorphine) versus antagonist (naloxone). Knowing the ceiling effect concept and why it matters clinically is essential.
2. NSAID safety rules — The 'never combine' rules appear as scenario questions with tragic outcomes. Memorise: no two NSAIDs simultaneously; no NSAID + corticosteroid; withhold before anaesthesia.
3. Local anaesthetic maximum doses in cats — Lidocaine cat 2 mg/kg (half the dog dose); bupivacaine cat 1 mg/kg. These limits protect against cardiac arrhythmia toxicity. Cat doses are tested more often than dog doses.
4. Feline Grimace Scale — Orbital tightening (squinting) is the primary pain indicator in cats. Many candidates are unaware that cats rarely vocalise pain — relying on vocalisation to detect feline pain is unreliable.
5. Buprenorphine route in cats — Oral transmucosal (OTM) administration is effective in cats because feline oral pH (~9) enhances mucosal absorption. OTM buprenorphine is NOT effective in dogs due to lower oral pH.
6. Multimodal analgesia concept — VTNE scenarios often describe a patient and ask for the best analgesic protocol — 'multimodal' (combining drug classes) is almost always the correct answer over a single high-dose drug.
7. Gabapentin — First-line for neuropathic and chronic pain due to central sensitisation. Also used pre-operatively in cats to reduce anxiety (facilitates handling and reduces stress-related pain amplification).
8. NSAIDs before surgery — Most NSAIDs should be withheld 24+ hours before elective surgery to preserve renal perfusion under general anaesthesia. Intraoperative hypotension combined with NSAID-reduced prostaglandins significantly increases the risk of acute kidney injury.
Memory Aid — Pain History: "WILDA" — Words (client/patient report), Intensity (scale score), Location, Duration, Aggravating/Alleviating factors
Local Anesthetic Maximum Dose Reference Table
Memorise these values — cat doses are the most frequently tested:
| Drug | Dog Maximum Dose | Cat Maximum Dose | Key Note |
|---|---|---|---|
| Lidocaine | 4 mg/kg | 2 mg/kg | Half dog dose; CNS/cardiac toxicity |
| Bupivacaine | 2 mg/kg | 1 mg/kg | Never IV; more cardiotoxic than lidocaine |
| Mepivacaine | 4–5 mg/kg | ~3 mg/kg | Less vasodilatory than lidocaine |
10 Free VTNE Pain Management Practice Questions
Each question mirrors the five-option format of the real VTNE. Work through each question before reading the explanation.
Q1: A cat receives buprenorphine 0.02 mg/kg via the oral transmucosal (OTM) route. Why is this route effective in cats but NOT in dogs?
A) Cats have thicker oral mucosa that absorbs drugs more rapidly
B) Cats have a higher oral pH (~9) that enhances buprenorphine absorption through the mucous membranes
C) Dogs metabolise buprenorphine too rapidly for OTM to be effective
D) Cats have fewer mu receptors, requiring a different delivery method
E) OTM in dogs causes excessive salivation that dilutes the drug
Answer: B — Cats have a higher oral pH (~9) that enhances buprenorphine mucosal absorption
Explanation: The cat's oral mucosa has a relatively alkaline pH (~9), which places buprenorphine in its un-ionised (lipid-soluble) form, significantly enhancing absorption across the mucous membrane into systemic circulation. In dogs, lower oral pH keeps buprenorphine ionised and poorly absorbed transmucosally. OTM buprenorphine in cats provides excellent analgesia for 4–8 hours and is widely used for post-operative and hospitalised patient pain management.
Q2: A technician applies a fentanyl transdermal patch to a dog for post-operative pain. What is the minimum time before therapeutic plasma levels are achieved?
A) 15–30 minutes
B) 1–2 hours
C) 6–12 hours
D) 24–36 hours
E) 48–72 hours
Answer: C — 6–12 hours
Explanation: Transdermal fentanyl patches require 6–12 hours to reach therapeutic plasma concentrations in dogs (approximately 12–24 hours in cats). Ideally the patch should be applied at least 12 hours before anticipated pain (e.g., the evening before surgery). For the immediate post-operative period, IV or IM opioids should bridge pain management until the patch becomes effective. Patch duration is approximately 72 hours in dogs.
Q3: Which of the following drug combinations is CONTRAINDICATED due to risk of serious gastrointestinal complications?
A) Morphine + gabapentin
B) Meloxicam + dexamethasone
C) Buprenorphine + fentanyl (at standard doses)
D) Gabapentin + tramadol
E) Lidocaine + bupivacaine at separate injection sites
Answer: B — Meloxicam + dexamethasone
Explanation: Combining an NSAID (meloxicam) with a corticosteroid (dexamethasone) is contraindicated. Both drug classes suppress prostaglandin-mediated GI mucosal protection through different pathways, and their combination dramatically increases the risk of GI ulceration, erosion, perforation, and haemorrhage. This drug combination rule is one of the most important pharmacological safety principles on the VTNE and is frequently presented as a scenario question.
Q4: A dog has a 3-year history of degenerative joint disease. The veterinarian prescribes gabapentin 10 mg/kg BID. What type of pain is gabapentin MOST effective for?
A) Acute traumatic pain from a laceration
B) Neuropathic pain and central sensitisation
C) Acute inflammatory pain from an active joint effusion
D) Visceral pain from intestinal distension
E) Surgical incisional pain in the first 24 hours post-op
Answer: B — Neuropathic pain and central sensitisation
Explanation: Gabapentin acts on voltage-gated calcium channels (specifically the alpha-2-delta subunit) to reduce neuronal excitability and dampen central sensitisation — the 'wind-up' phenomenon in which the spinal cord becomes hypersensitised in chronic pain conditions. It is most effective for neuropathic pain. It is also used pre-operatively in cats at low doses to reduce anxiety and pain sensitisation, improving handling and reducing stress hormones.
Q5: The maximum safe dose of lidocaine for a cat undergoing a dental nerve block is:
A) 8 mg/kg
B) 4 mg/kg
C) 2 mg/kg
D) 1 mg/kg
E) 0.5 mg/kg
Answer: C — 2 mg/kg
Explanation: The maximum safe dose of lidocaine in cats is 2 mg/kg — exactly half the dog maximum of 4 mg/kg. Cats are more susceptible to local anaesthetic toxicity due to differences in hepatic cytochrome P450 enzyme activity and slower drug metabolism. Overdose causes CNS signs (tremors, seizures) followed by cardiovascular collapse. For reference, bupivacaine maximum is 1 mg/kg in cats versus 2 mg/kg in dogs.
Q6: During a pain assessment, a hospitalised post-surgical dog scores 3/10 on the Numerical Rating Scale, shows mild abdominal guarding, and is eating readily. What is the MOST appropriate action for the veterinary technician?
A) Administer full-dose IV morphine immediately
B) Continue monitoring without intervention — the score does not warrant action
C) Document the findings and notify the supervising veterinarian for analgesic assessment
D) Apply a fentanyl patch and discontinue pain score monitoring
E) Administer a second NSAID for breakthrough pain
Answer: C — Document and notify the veterinarian
Explanation: Any pain score indicating ongoing discomfort, combined with behavioural signs such as guarding, should be documented and communicated to the veterinarian, who will determine whether to adjust the analgesic protocol. Pain management in hospitalised patients should be dynamic and reassessed at regular intervals. The technician's scope is accurate assessment and reporting — not independently administering unordered medications. Administering a second NSAID would violate the cardinal NSAID safety rule.
Q7: A multimodal analgesic protocol is prescribed for a dog undergoing tibial plateau levelling osteotomy (TPLO). Which combination BEST represents multimodal analgesia?
A) Two NSAIDs at half doses each to reduce side effects
B) High-dose morphine as the sole analgesic
C) Hydromorphone (opioid) + meloxicam (NSAID) + local bupivacaine nerve block
D) Fentanyl + buprenorphine (two opioids simultaneously)
E) Acepromazine + glycopyrrolate
Answer: C — Hydromorphone + meloxicam + local bupivacaine nerve block
Explanation: Multimodal analgesia requires combining drugs from genuinely different analgesic classes that act at different points in the pain pathway. Option C uses three classes: an opioid (central mu receptor agonist), an NSAID (peripheral COX inhibitor), and a local anaesthetic (peripheral sodium channel blockade). This achieves synergistic analgesia at lower individual doses. Using two NSAIDs violates the NSAID safety rule; using two opioids from the same class is redundant and does not constitute multimodal analgesia.
Q8: Naloxone is administered to reverse opioid over-sedation in a post-surgical dog. What is the MOST significant clinical concern with naloxone administration?
A) Hepatotoxicity from rapid hepatic metabolism
B) Simultaneous reversal of analgesia along with sedation, precipitating an acute pain crisis
C) Cardiovascular depression and bradycardia
D) Respiratory stimulation causing significant hypocapnia
E) Prolonged half-life preventing future opioid administration
Answer: B — Reversal of analgesia along with sedation, precipitating an acute pain crisis
Explanation: Naloxone reverses ALL opioid effects simultaneously — both the undesirable sedation and the therapeutic analgesia. In a post-surgical patient with ongoing pain, this can precipitate an acute pain crisis accompanied by sympathetic stimulation (tachycardia, hypertension, agitation). To minimise this risk, naloxone should be titrated IV in small incremental doses (0.002–0.01 mg/kg) until the desired level of reversal is achieved, rather than administering a full reversal dose. Have a plan for pain management if opioid reversal is necessary.
Q9: A horse shows signs of colic including pawing, flank-watching, and repeatedly lying down. Which analgesic is MOST commonly used as first-line treatment for equine colic pain?
A) Morphine IM
B) Buprenorphine IV
C) Flunixin meglumine (Banamine) IV
D) Meloxicam PO
E) Gabapentin PO
Answer: C — Flunixin meglumine (Banamine) IV
Explanation: Flunixin meglumine is the most widely used analgesic for equine colic and is considered the drug of choice for visceral (GI) pain in horses. It is a potent NSAID administered IV in hospital settings. IM administration in horses is discouraged due to risk of clostridial myonecrosis at the injection site. Opioids such as butorphanol may be used concurrently for severe pain, but pure mu agonists can reduce GI motility, potentially worsening the underlying colic if the cause is ileus.
Q10: Which opioid receptor type primarily mediates the analgesic effects of full agonist opioids in veterinary patients?
A) Kappa (kappa) receptor
B) Delta (delta) receptor
C) Mu (mu) receptor
D) Sigma (sigma) receptor
E) Nociceptin (NOP) receptor
Answer: C — Mu (mu) receptor
Explanation: The mu (mu) opioid receptor mediates the majority of clinically significant analgesic effects, as well as sedation, euphoria, and the principal side effects: respiratory depression, urinary retention, and GI hypomotility (ileus). Full mu agonists (morphine, hydromorphone, fentanyl) provide the most potent and reliable analgesia. Kappa receptors contribute to spinal-level analgesia and sedation (butorphanol acts primarily at kappa receptors). Delta receptors modulate mood and some analgesia but are not the primary clinical target.
Study Tips for D9 Pain Management
1. Learn the opioid hierarchy — Full agonists (strongest) > partial agonist with ceiling effect (buprenorphine) > mixed agonist-antagonist (butorphanol) > antagonist (naloxone). Know one drug example for each class and its primary receptor target.
2. Memorise NSAID safety rules — Never combine two NSAIDs; never NSAID + corticosteroid; withhold 24+ hours before elective surgery. These exact clinical rules are presented as scenario questions where violating the rule leads to a complication — choosing the safe option scores the point.
3. Know local anaesthetic max doses (cat doses are the exam focus) — Lidocaine dog 4 mg/kg, cat 2 mg/kg; bupivacaine dog 2 mg/kg, cat 1 mg/kg. The cat dose is always half the dog dose. These numbers appear as direct answer choices.
4. The Feline Grimace Scale: orbital tightening is key — Cats rarely vocalise pain. The primary indicator of feline pain is orbital tightening (squinting). Candidates who rely on vocalisation to identify pain in cats will miss this clinical distinction on exam questions and in practice.
Frequently Asked Questions
How many pain management questions are on the VTNE?
D9 Pain Management accounts for 7% of the VTNE — approximately 10–11 scored questions. Because pain assessment and pharmacology are integrated into clinical reasoning scenarios, performance in D9 often correlates with overall exam performance.
What pain topics are most tested on the VTNE?
Opioid classification (full agonist vs partial agonist vs antagonist), NSAID safety rules (never combine, never use with corticosteroids, withhold before surgery), local anaesthetic maximum doses in cats, and the multimodal analgesia concept are the highest-yield D9 topics.
Is buprenorphine a full opioid agonist?
No — buprenorphine is a partial mu-receptor agonist. This means it exhibits a ceiling effect: increasing the dose beyond a threshold does not proportionally increase analgesia, and respiratory depression risk is lower than with full agonists. It is an excellent analgesic for mild to moderate pain, particularly in cats via the oral transmucosal route where its alkaline-pH absorption advantage makes it highly practical for home analgesia.
Want all D9 Pain Management questions? Start free practice: Free VTNE Practice Exam